BNP-targeted nano antibody as well as preparation method and application thereof

By developing nano-antibody targeting BNP and its preparation method, the problems of high cost and poor heat resistance of traditional monoclonal antibodies in BNP detection are solved, and the specific binding of high affinity to BNP protein is achieved, which is suitable for rapid detection kits , provides efficient and accurate diagnostic tools.

CN118930651APending Publication Date: 2024-11-12NATIONAL INSTITUTE OF METROLOGY CHINA +1
0 Cites 2 Cited by

Patent Information

Application Number
CN202411021519.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-29
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The existing BNP detection kits on the market use the traditional monoclonal antibody diabody sandwich method to detect defects such as high cost, poor heat resistance and unsuitable for small molecule sample detection, making it difficult to meet the needs of efficient, fast and accurate in vitro diagnosis.

Method used

A nano-antibody targeting BNP and its preparation method were developed. High affinity and high affinity and BNP protein-bound nano-antibodies.

Benefits of technology

A high-affinity and strong specificity nano-antibody was obtained, which can effectively bind BNP in vitro, and is suitable for the development of rapid detection kits. It provides efficient and accurate diagnostic tools, with important commercial value and clinical application potential.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention discloses a nano antibody for targeting BNP (Brain Natriuretic Peptide) as well as a preparation method and application of the nano antibody. The amino acid sequences of CDR1, CDR2 and CDR3 of the nano antibody are respectively shown as SEQ ID NO: 1-3. The preparation method comprises the following steps: (1) constructing a prokaryotic expression vector and expressing recombinant protein by using an escherichia coli prokaryotic expression system; (2) carrying out alpaca immunization by utilizing the prepared recombinant protein to prepare a nano antibody library; (3) performing solid-phase panning of the nano antibody through a phage display system; (4) carrying out sequencing to obtain a nano antibody sequence, and then carrying out prokaryotic expression and identification; and (5) carrying out Western and Biacore identification to obtain the nano antibody which is combined with the BNP protein in a high affinity manner. The high-affinity nano antibody targeting the BNP is obtained, a tool can be provided for clinical disease diagnosis and treatment through in-vitro mass expression and transformation, and the high-affinity nano antibody has important commercial value.
Need to check novelty before this filing date? Find Prior Art